These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 23465646)

  • 21. "Word of mouse": indigenous harm reduction and online consumerism of the synthetic compound methoxphenidine.
    Van Hout MC; Hearne E
    J Psychoactive Drugs; 2015; 47(1):30-41. PubMed ID: 25715070
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The deterrent effects of Australian street-level drug law enforcement on illicit drug offending at outdoor music festivals.
    Hughes CE; Moxham-Hall V; Ritter A; Weatherburn D; MacCoun R
    Int J Drug Policy; 2017 Mar; 41():91-100. PubMed ID: 28131615
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An Internet Study of User's Experiences of the Synthetic Cathinone 4-Methylethcathinone (4-MEC).
    Van Hout MC
    J Psychoactive Drugs; 2014; 46(4):273-86. PubMed ID: 25188697
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mixing politics and crime - The prevalence and decline of political discourse on the cryptomarket.
    Munksgaard R; Demant J
    Int J Drug Policy; 2016 Sep; 35():77-83. PubMed ID: 27424175
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Concepts of illicit drug quality among darknet market users: Purity, embodied experience, craft and chemical knowledge.
    Bancroft A; Scott Reid P
    Int J Drug Policy; 2016 Sep; 35():42-9. PubMed ID: 26777135
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Information sought, information shared: exploring performance and image enhancing drug user-facilitated harm reduction information in online forums.
    Tighe B; Dunn M; McKay FH; Piatkowski T
    Harm Reduct J; 2017 Jul; 14(1):48. PubMed ID: 28732534
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Internet and psychoactive substance use among innovative drug users.
    Boyer EW; Shannon M; Hibberd PL
    Pediatrics; 2005 Feb; 115(2):302-5. PubMed ID: 15687436
    [TBL] [Abstract][Full Text] [Related]  

  • 28. User information seeking behaviour: perceptions and reality. An evaluation of the WHO Labresources Internet portal.
    Madle G; Berger A; Cognat S; Menna S; Kostkova P
    Inform Health Soc Care; 2009 Jan; 34(1):30-8. PubMed ID: 19306197
    [TBL] [Abstract][Full Text] [Related]  

  • 29. e-Psychonauts: conducting research in online drug forum communities.
    Davey Z; Schifano F; Corazza O; Deluca P;
    J Ment Health; 2012 Aug; 21(4):386-94. PubMed ID: 22823094
    [TBL] [Abstract][Full Text] [Related]  

  • 30. #Drugsforsale: An exploration of the use of social media and encrypted messaging apps to supply and access drugs.
    Moyle L; Childs A; Coomber R; Barratt MJ
    Int J Drug Policy; 2019 Jan; 63():101-110. PubMed ID: 30530252
    [TBL] [Abstract][Full Text] [Related]  

  • 31. New psychoactive substances: Purchasing and supply patterns in Australia.
    Sutherland R; Bruno R; Peacock A; Dietze P; Breen C; Burns L; Barratt MJ
    Hum Psychopharmacol; 2017 May; 32(3):. PubMed ID: 28517235
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Community-consumerism: negotiating risk in online drug communities.
    Bilgrei OR
    Sociol Health Illn; 2019 Jun; 41(5):852-866. PubMed ID: 30675725
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Presence of New Psychoactive Substances in a Tor Network Marketplace Environment.
    Dolliver DS; Kuhns JB
    J Psychoactive Drugs; 2016; 48(5):321-329. PubMed ID: 27660913
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fentanyl use among street drug users in Toronto, Canada: behavioural dynamics and public health implications.
    Firestone M; Goldman B; Fischer B
    Int J Drug Policy; 2009 Jan; 20(1):90-2. PubMed ID: 18508256
    [TBL] [Abstract][Full Text] [Related]  

  • 35. "Spice," "kryptonite," "black mamba": an overview of brand names and marketing strategies of novel psychoactive substances on the web.
    Corazza O; Valeriani G; Bersani FS; Corkery J; Martinotti G; Bersani G; Schifano F
    J Psychoactive Drugs; 2014; 46(4):287-94. PubMed ID: 25188698
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An island apart? Risks and prices in the Australian cryptomarket drug trade.
    Cunliffe J; Martin J; Décary-Hétu D; Aldridge J
    Int J Drug Policy; 2017 Dec; 50():64-73. PubMed ID: 29055855
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The diverse reasons for using Novel Psychoactive Substances - A qualitative study of the users' own perspectives.
    Soussan C; Andersson M; Kjellgren A
    Int J Drug Policy; 2018 Feb; 52():71-78. PubMed ID: 29241144
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The "Darknet": The new street for street drugs.
    Pergolizzi JV; LeQuang JA; Taylor R; Raffa RB;
    J Clin Pharm Ther; 2017 Dec; 42(6):790-792. PubMed ID: 28921578
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Disruptive Potential of the Internet to Transform Illicit Drug Markets and Impact on Future Patterns of Drug Consumption.
    Griffiths P; Mounteney J
    Clin Pharmacol Ther; 2017 Feb; 101(2):176-178. PubMed ID: 27995611
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Monitoring new psychoactive substances: Exploring the contribution of an online discussion forum.
    Rhumorbarbe D; Morelato M; Staehli L; Roux C; Jaquet-Chiffelle DO; Rossy Q; Esseiva P
    Int J Drug Policy; 2019 Nov; 73():273-280. PubMed ID: 30967328
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.